Addex Therapeutics ADXN
NASDAQ ADXN
$2.79 -0.16 (-5.58%)
As of: Sep 30, 2026 · 12:11 PM EDT

Addex Therapeutics Ltd. (ADXN) Research & Development (2017 - 2026)

Updated

Addex Therapeutics (ADXN) posted Research & Development of -$48.06 million for Q2 2026, compared with -$283.19 million a year earlier.

Analysis

Addex Therapeutics Ltd. (ADXN) Research & Development (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Addex Therapeutics was -$379.69 million; for FY2025, it was -$840,349.

  • In prior years, Addex Therapeutics' Research & Development was -$971,090 in FY2024, -$1.34 million in FY2023, -$8.56 million in FY2022 and -$13.93 million in FY2021.
  • Quarterly Research & Development has run from a low of -$285.43 million in Q3 2025 to a high of $5.97 million in Q2 2022 over five years.
  • According to Business Quant data, Research & Development for the three prior quarters was -$46.14 million (Q1 2026), -$66,073 (Q4 2025) and -$285.43 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.06 Mn
Mar 31, 2026 -46.14 Mn
Dec 31, 2025 -66,073.03
Sep 30, 2025 -285.43 Mn
Jun 30, 2025 -283.19 Mn
Mar 31, 2025 -173.58 Mn
Dec 31, 2024 -74,597.31
Sep 30, 2024 -236.05 Mn
Jun 30, 2024 -375,214.53
Mar 31, 2024 -280,692.17
Dec 31, 2023 -168,046.84
Sep 30, 2023 -555,532.54
Jun 30, 2023 -324,281.47
Mar 31, 2023 -275,696.46
Dec 31, 2022 -15.22 Mn
Sep 30, 2022 -2.86 Mn
Jun 30, 2022 5.97 Mn
Mar 31, 2022 -4.08 Mn
Dec 31, 2021 -13.93 Mn
Sep 30, 2021 -3.12 Mn
API Access

Addex Therapeutics Ltd. Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ADXN&period=max&api_key=YOUR_API_KEY